Some eight months into the launch of Onapgo, the Parkinson’s disease infusion pump Supernus Pharmaceuticals spent years fighting to get across the FDA finish line, the drugmaker is discovering that patients’ appetite for the wearable is more than it can
read moreIn a letter to lawyers for Novo and Metsera, an FTC official wrote that the proposed purchase of Metsera by the Danish pharma “may violate the procedural provisions” of the Hart-Scott-Rodino (HSR) Act. More: FTC warns Novo that current Metsera
read moreTeva Pharmaceuticals has a new game plan for raising awareness of tardive dyskinesia. More: Teva drafts NFL star Terrell Davis for tardive dyskinesia awareness drive Source: fierce
read moreThe company remains confident in the continued sales potential of Austedo after wrapping up government negotiations that will change the Medicare price for its top-seller in 2027. More: Teva CEO touts 'defining strength' of innovative drugs as its sales grow
read moreMadrigal’s Rezdiffra generated sales of $287 million in the third quarter for a 35% sequential jump from Q2. In just its fifth full quarter on the market, the world’s first treatment for metabolic dysfunction-associated steatohepatitis (MASH) is now annualizing at
read more© 1994 - 2025 B.M. Pharmaceuticals